13 0

- Non-small cell lung cancer is the leading cause of cancer death in the world - Immunotherapy plus chemotherapy nearly doubled survival of patients with advanced disease. (CNN) Combining an immunotherapy drug with chemotherapy nearly doubled the survival time of some lung cancer patients compared to patients treated with chemotherapy alone, new research published Monday in the New England Journal of Medicine showed. The study results apply only to patients whose lung cancer does not begin in the squamous cells (or surface lung cell layer) and who also lack certain genetic mutations. Of the two types of lung cancer , small cell lung cancer is less common than non-small cell lung cancer, wh... Full story

16 April